The New York Entrepreneur

: Wall Street analysts predict approval for another ALS drug

Read Time:8 Second

An FDA advisory committee is set to meet this week to discuss a drug developed by Biogen and Ionis to treat a rare form of Lou Gehrig’s disease.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Encore: Social Security is the most valuable program in this country. Let’s stop cutting its operating budget.
Next post Retirement Hacks: You never know what might crash your retirement. How to create a ‘Plan B.’